Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare

Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare
复制标题

DOI:
10.1111/j.1742-1241.2008.01707.x
复制
发表时间:
2008-04-01
影响因子:
2.6
通讯作者:
Miravitlles, M.
Miravitlles, M.
中科院分区:
医学4区
文献类型:
--
作者:
Llor, C.;Molina, J.;Miravitlles, M.

文献摘要

被引文献

相似文献

目的:调查慢性阻塞性肺疾病 (COPD) 患者生活质量的演变,并量化两年内病情加重对生活质量恶化的影响。方法:在初级保健中进行了为期 2 年的多中心、观察性、前瞻性研究。 COPD 患者每 6 个月就诊一次。记录研究期间发生的所有病情恶化,并使用圣乔治呼吸问卷(SGRQ)测量这些患者的生活质量。结果:27 名医生参与并收集了 136 名患者的信息,患者平均年龄为 70 岁(SD:9.7),平均 1 秒用力呼气量(FEV1)为预测值的 48.7%(SD:14.5%)。研究开始时 SGRQ 的平均全球分数为 39.6,研究结束时为 37.9。没有病情加重的患者平均改善了 -5.32 个单位,而病情加重的患者则平均恶化了 +0.2 个单位 (p = 0.023)。在后者中,只有一次恶化的患者改善了 -3.8 个单位 (p = 0.012),而两次或多次恶化的患者则恶化了 +2.4 个单位 (p = 0.134)。肺功能保存较好的患者中,病情加重的影响更大,有或无加重的患者中,FEV1 > 50% 的患者 SGRQ 变化分别为 +0.23 和 -6.17 (p = 0.017),而 FEV1 患者的 SGRQ 变化分别为 +0.18 和 -4.39 (p = 0.32)
Aims: To investigate the evolution of the quality of life of patients with chronic obstructive pulmonary disease (COPD) and quantify the impact of exacerbations on the deterioration of quality of life over 2 years. Methods: Multicentre, observational, prospective 2-year study carried out in primary care. Patients with COPD were seen every 6 months. All the exacerbations developing during the study period were recorded and the quality of life of these patients was measured with the St. George's Respiratory Questionnaire (SGRQ). Results: Twenty-seven physicians participated and collected information on 136 patients with a mean age of 70 years (SD: 9.7) and a mean forced expiratory volume in 1 s (FEV1) of 48.7% predicted (SD: 14.5%). The mean global score of the SGRQ was 39.6 at the beginning of the study and 37.9 at the end. Patients without exacerbations improved an average of -5.32 units compared with a worsening of +0.2 among patients with exacerbations (p = 0.023). Among the latter, patients with only one exacerbation improved -3.8 units (p = 0.012) compared with a worsening of +2.4 in those with two or more exacerbations (p = 0.134). The impact of exacerbations was greater in patients with more preserved pulmonary function, with a change in the SGRQ among patients with or without exacerbations of +0.23 and -6.17 (p = 0.017), respectively in patients with a FEV1 > 50%, vs. +0.18 and -4.39 (p = 0.32) in patients with a FEV1